Roth Capital analyst Ed Arce reiterated a Buy rating on Conatus Pharmaceuticals (NASDAQ:CNAT) with a price target of $19, which represents a potential …
On November 25th, the Food and Drug Administration announced new nutrition labeling laws that require all chain restaurants to “clearly and conspicuously “post …
In a research report sent to investors today, H.C.
In a research report sent to investors today, Roth Capital analyst Debjit Chattopadhyay maintained a Buy rating on Sarepta Therapeutics Inc. (NASDAQ:SRPT) with …
Apple Inc. (NASDAQ:AAPL) tops Goldman Sachs’ list of “Very Important Positions” again this time around.
In a research note issued today, Deutsche Bank analyst Alethia Young maintained a Buy rating on Avanir Pharmaceuticals (NASDAQ:AVNR) with a $17 price target, following numerous presentations of …
In a research report issued today, H.C.
UBS analyst Brent Thill reiterated a Buy rating on Splunk (NASDAQ:SPLK) and raised his price target to $73 (from $64), which represents a …
Roth Capital analyst Philip Shen reiterated a Buy rating on Trina Solar Limited (NYSE:TSL) with a $25 price target, which implies an upside of …
In a research report released Thursday, Cantor analyst Irina Rivkind maintained a Buy rating on Synergy Pharmaceuticals (NASDAQ:SGYP) and slightly raised her price target to $8.50 …
